DK1274402T3 - Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamol - Google Patents
Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamolInfo
- Publication number
- DK1274402T3 DK1274402T3 DK01933832T DK01933832T DK1274402T3 DK 1274402 T3 DK1274402 T3 DK 1274402T3 DK 01933832 T DK01933832 T DK 01933832T DK 01933832 T DK01933832 T DK 01933832T DK 1274402 T3 DK1274402 T3 DK 1274402T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- acetaminophen
- controlled release
- release phase
- paracetamol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Confectionery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0009522.4A GB0009522D0 (en) | 2000-04-19 | 2000-04-19 | Composition |
PCT/EP2001/004302 WO2001080834A1 (en) | 2000-04-19 | 2001-04-12 | Composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1274402T3 true DK1274402T3 (da) | 2009-11-16 |
Family
ID=9890126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01933832T DK1274402T3 (da) | 2000-04-19 | 2001-04-12 | Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamol |
Country Status (25)
Country | Link |
---|---|
US (2) | US7943170B2 (uk) |
EP (1) | EP1274402B1 (uk) |
JP (1) | JP2003531165A (uk) |
KR (1) | KR100845660B1 (uk) |
CN (1) | CN100335046C (uk) |
AT (1) | ATE438388T1 (uk) |
AU (2) | AU6021201A (uk) |
BR (1) | BR0110129A (uk) |
CA (1) | CA2406373C (uk) |
CO (1) | CO5280073A1 (uk) |
CY (1) | CY1109483T1 (uk) |
CZ (1) | CZ303275B6 (uk) |
DE (1) | DE60139462D1 (uk) |
DK (1) | DK1274402T3 (uk) |
EA (1) | EA006103B1 (uk) |
ES (1) | ES2329971T3 (uk) |
GB (1) | GB0009522D0 (uk) |
HK (1) | HK1053601A1 (uk) |
HU (1) | HU230033B1 (uk) |
MX (1) | MXPA02010347A (uk) |
NZ (1) | NZ521799A (uk) |
TW (1) | TWI282286B (uk) |
UA (1) | UA76417C2 (uk) |
WO (1) | WO2001080834A1 (uk) |
ZA (1) | ZA200208084B (uk) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0009522D0 (en) * | 2000-04-19 | 2000-06-07 | Smithkline Beecham Plc | Composition |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US20040186180A1 (en) * | 2003-03-21 | 2004-09-23 | Gelotte Cathy K. | Non-steroidal anti-inflammatory drug dosing regimen |
CN100348974C (zh) * | 2003-09-30 | 2007-11-14 | 北京东方凯恩医药科技有限公司 | 一种药物组合物的检测方法 |
US20050095299A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
ES2389666T3 (es) | 2005-09-09 | 2012-10-30 | Angelini Labopharm, Llc | Composición de trazodona para una administración de una vez al día |
US20080057122A1 (en) * | 2006-08-31 | 2008-03-06 | Aaipharma Inc. | Acetaminophen pharmaceutical compositions |
MX336494B (es) * | 2007-10-16 | 2016-01-21 | Paladin Labs Inc | Composicion de bicapas para la liberacion controlada de acetaminofeno y tramadol. |
KR20100121463A (ko) | 2007-12-17 | 2010-11-17 | 라보팜 인코포레이트 | 오용 예방적 방출 제어형 제제 |
US9226907B2 (en) | 2008-02-01 | 2016-01-05 | Abbvie Inc. | Extended release hydrocodone acetaminophen and related methods and uses thereof |
US8372432B2 (en) | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
CA2720108C (en) | 2008-03-11 | 2016-06-07 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
ES2509497T3 (es) | 2008-12-16 | 2014-10-17 | Paladin Labs Inc. | Formulación de liberación controlada para evitar un uso indebido |
EP2395840B1 (en) * | 2009-02-13 | 2020-04-15 | Romark Laboratories, L.C. | Controlled release pharmaceutical formulations of nitazoxanide |
US20110052685A1 (en) * | 2009-08-31 | 2011-03-03 | Depomed, Inc. | Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US20140065213A1 (en) * | 2011-05-06 | 2014-03-06 | GlaxoSmithKline, LLC | Sustained Release Paracetamol Formulations |
US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US9050335B1 (en) | 2011-05-17 | 2015-06-09 | Mallinckrodt Llc | Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia |
US20140206740A1 (en) * | 2011-07-30 | 2014-07-24 | Neurovance, Inc. | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
AU2013330993B2 (en) * | 2012-10-18 | 2018-03-01 | Abbvie Inc. | Formulations of pyrimidinedione derivative compounds |
WO2016042570A1 (en) * | 2014-09-16 | 2016-03-24 | Suresh Pareek | Extended release formulation of acetaminophen |
BR112018068143A2 (pt) | 2016-03-09 | 2019-07-30 | Nls 1 Pharma Ag | forma farmacêutica unitária oral de mazindol na forma de comprimido do tipo multicamada e processo para preparar dita forma farmacêutica |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2058562B (en) * | 1979-09-14 | 1983-11-30 | Beecham Group Ltd | Pharmaceutical compositions containing paracetamol and ascorbic acid |
US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
US4820522A (en) * | 1987-07-27 | 1989-04-11 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
EP0418596A3 (en) * | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
US5009895A (en) * | 1990-02-02 | 1991-04-23 | Merck & Co., Inc. | Sustained release with high and low viscosity HPMC |
US5900425A (en) * | 1995-05-02 | 1999-05-04 | Bayer Aktiengesellschaft | Pharmaceutical preparations having controlled release of active compound and processes for their preparation |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
FR2766708B1 (fr) | 1997-07-30 | 2000-05-05 | Galenix Dev | Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention |
US5945123A (en) * | 1998-04-02 | 1999-08-31 | K-V Pharmaceutical Company | Maximizing effectiveness of substances used to improve health and well being |
US6254891B1 (en) | 1998-09-03 | 2001-07-03 | Ascent Pediatrics, Inc. | Extended release acetaminophen |
US6126967A (en) * | 1998-09-03 | 2000-10-03 | Ascent Pediatrics | Extended release acetaminophen particles |
GB0009522D0 (en) * | 2000-04-19 | 2000-06-07 | Smithkline Beecham Plc | Composition |
US7897172B2 (en) * | 2004-05-18 | 2011-03-01 | L. Perrigo Company | Tablets exhibiting reduced drug release variability |
-
2000
- 2000-04-19 GB GBGB0009522.4A patent/GB0009522D0/en not_active Ceased
-
2001
- 2001-04-12 ES ES01933832T patent/ES2329971T3/es not_active Expired - Lifetime
- 2001-04-12 CA CA2406373A patent/CA2406373C/en not_active Expired - Fee Related
- 2001-04-12 MX MXPA02010347A patent/MXPA02010347A/es active IP Right Grant
- 2001-04-12 WO PCT/EP2001/004302 patent/WO2001080834A1/en active IP Right Grant
- 2001-04-12 NZ NZ521799A patent/NZ521799A/xx not_active IP Right Cessation
- 2001-04-12 EA EA200200954A patent/EA006103B1/ru not_active IP Right Cessation
- 2001-04-12 DE DE60139462T patent/DE60139462D1/de not_active Expired - Lifetime
- 2001-04-12 AU AU6021201A patent/AU6021201A/xx active Pending
- 2001-04-12 DK DK01933832T patent/DK1274402T3/da active
- 2001-04-12 US US10/257,077 patent/US7943170B2/en not_active Expired - Fee Related
- 2001-04-12 KR KR1020027014009A patent/KR100845660B1/ko active IP Right Grant
- 2001-04-12 CZ CZ20023470A patent/CZ303275B6/cs not_active IP Right Cessation
- 2001-04-12 AU AU2001260212A patent/AU2001260212C1/en not_active Expired
- 2001-04-12 BR BR0110129-3A patent/BR0110129A/pt active Search and Examination
- 2001-04-12 EP EP01933832A patent/EP1274402B1/en not_active Expired - Lifetime
- 2001-04-12 CN CNB018084036A patent/CN100335046C/zh not_active Expired - Lifetime
- 2001-04-12 JP JP2001577934A patent/JP2003531165A/ja active Pending
- 2001-04-12 AT AT01933832T patent/ATE438388T1/de not_active IP Right Cessation
- 2001-04-12 HU HU0300698A patent/HU230033B1/hu not_active IP Right Cessation
- 2001-04-17 CO CO01029583A patent/CO5280073A1/es not_active Application Discontinuation
- 2001-04-18 TW TW090109284A patent/TWI282286B/zh not_active IP Right Cessation
- 2001-12-04 UA UA2002108076A patent/UA76417C2/uk unknown
-
2002
- 2002-10-08 ZA ZA200208084A patent/ZA200208084B/en unknown
-
2003
- 2003-06-16 HK HK03104302.2A patent/HK1053601A1/xx not_active IP Right Cessation
-
2009
- 2009-10-13 CY CY20091101055T patent/CY1109483T1/el unknown
-
2011
- 2011-03-29 US US13/074,944 patent/US20110177168A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1274402T3 (da) | Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamol | |
DK1023050T3 (da) | Nye formuleringer af farmakologiske midler, fremgangsmåder til fremstillingen deraf og fremgangsmåder til anvendelsen deraf | |
DK2158905T3 (da) | Sammensætning til transdermal administration af fentanyl | |
DK1131070T3 (da) | Farmaceutisk sammensætning til modificeret frigivelse af en insulin- sensibilisator og metformin | |
NO20024528L (no) | Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen | |
CY1112517T1 (el) | Φαρμακοτεχνικες μορφες τροποποιημενης αποδεσμευσης μιας τουλαχιστον μορφης τραμαδολης | |
DK1726658T3 (da) | Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf | |
AR028372A1 (es) | Dispositivos de administracion de drogas de liberacion sostenida, metodos de uso y metodos de fabricacion de los mismos | |
NO20025592L (no) | Kontinuerlig produksjon av farmasöytisk granulering | |
DK0991654T3 (da) | Hidtil ukendte derivater af 2-(iminomethyl)aminophenyl, deres fremstilling, deres anvendelse til medikamenter og farmaceutiske præparater indeholdende samme | |
IS6811A (is) | Lyfjafræðilegar samsetningar NMDA viðtakagerandefna | |
DK1334182T3 (da) | Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf | |
CY1110906T1 (el) | Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης | |
EE200200393A (et) | Glüburiidi ravimkoostis | |
DK1349580T4 (da) | Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning | |
DK1108424T3 (da) | Matrixtablet til langvarig frisætning af | |
DK1475379T3 (da) | Anvendelse af scopinesterderivater til fremstilling af lægemidler | |
DK1465602T3 (da) | Matrix-filmtablet med kontrolleret frigivelse af naturlige blandinger af konjugerede östrogener | |
DK1339723T3 (da) | Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner | |
BR0114590A (pt) | Processo para a preparação de tabletes | |
DK1345605T3 (da) | Varmformet lægemiddelsammensætning til styret afgivelse af perindopril | |
NO20024679D0 (no) | Krystallinsk farmasöytikum | |
EA200201062A1 (ru) | Фармацевтическая композиция на основе нестероидного противовоспалительного средства | |
ATE331509T1 (de) | Zusammensetzung die paracetamol und niflumic säure enthält | |
ATE303135T1 (de) | Pharmazeutische formulierungen zur gesteuerten freisetzung von 4-amino-6,7-dimethoxy-2-(5- |